APP‐derived peptides reflect neurodegeneration in frontotemporal dementia. Issue 12 (2nd December 2019)

• Record Type: Journal Article
• Authors: Illán‐Gala, Ignacio; Pegueroles, Jordi; Montal, Victor; Alcolea, Daniel; Vilaplana, Eduard; Bejanin, Alexandre; Borrego‐Écija, Sergi; Sampedro, Frederic; Subirana, Andrea; Sánchez‐Saudinós, María‐Belén; Rojas‐García, Ricard; Vanderstichele, Hugo; Blesa, Rafael; Clarimón, Jordi; Antonell, Anna; Lladó, Albert; Sánchez‐Valle, Raquel; Fortea, Juan; Lleó, Alberto
• Is Part Of: Annals of clinical and translational neurology. Volume 6:Issue 12(2019)
• Page Start: 2518
• Page End: 2530
• Publication Date: 2019-12-02
• Subjects: Nervous system -- Diseases -- Periodicals; Neurology -- Periodicals; 616.8005
• DOI: 10.1002/acn3.50948
• Languages: English
• ISSNs: 2328-9503

Abstract

Abstract: Objective: We aimed to investigate the relationship between cerebrospinal fluid levels (CSF) of amyloid precursor protein (APP)‐derived peptides related to the amyloidogenic pathway, cortical thickness, neuropsychological performance, and cortical gene expression profiles in frontotemporal lobar degeneration (FTLD)‐related syndromes, Alzheimer's disease (AD), and healthy controls. Methods: We included 214 participants with CSF available recruited at two centers: 93 with FTLD‐related syndromes, 57 patients with AD, and 64 healthy controls. CSF levels of amyloid β (Aβ)1‐42, Aβ1‐40, Aβ1‐38, and soluble β fragment of APP (sAPPβ) were centrally analyzed. We compared CSF levels of APP‐derived peptides between groups and, we studied the correlation between CSF biomarkers, cortical thickness, and domain‐specific cognitive composites in each group. Then, we explored the relationship between cortical thickness, CSF levels of APP‐derived peptides, and regional gene expression profile using a brain‐wide regional gene expression data in combination with gene set enrichment analysis. Results: The CSF levels of Aβ1‐40, Aβ1‐38, and sAPPβ were lower in the FTLD‐related syndromes group than in the AD and healthy controls group. CSF levels of all APP‐derived peptides showed a positive correlation with cortical thickness and the executive cognitive composite in the FTLD‐related syndromes group but not in the healthy control or AD groups. In the cortical regions where we observed a significant association between cortical thickness and CSF levels of APP‐derived peptides, we found a reduced expression of genes related to synaptic function. Interpretation: APP‐derived peptides in CSF may reflect FTLD‐related neurodegeneration. This observation has important implications as Aβ1‐42 levels are considered an indirect biomarker of cerebral amyloidosis.